Get the Stockscreener App
74.20
3.56%
-2.74
After Hours:
74.20
Solventum Corp stock is traded at $74.20, with a volume of 2.24M.
It is down -3.56% in the last 24 hours and down -4.39% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$76.94
Open:
$73
24h Volume:
2.24M
Relative Volume:
2.09
Market Cap:
$12.87B
Revenue:
$8.42B
Net Income/Loss:
$1.52B
P/E Ratio:
8.5414
EPS:
8.6871
Net Cash Flow:
$56.00M
1W Performance:
+1.73%
1M Performance:
-4.39%
6M Performance:
+1.80%
1Y Performance:
-11.07%
1-Day Range:
$73.00
$77.89
1-Week Range:
$71.49
$77.89
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.20 | 13.35B | 8.42B | 1.52B | 56.00M | 8.6871 |
|
ISRG
Intuitive Surgical Inc
|
503.51 | 180.01B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
176.48 | 50.25B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
87.18 | 42.27B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.51 | 39.67B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.26 | 37.45B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down - Zacks Investment Research
Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. - Barron's
Solventum (SOLV) Maintains Overweight Rating with Raised Price T - GuruFocus
Piper Sandler reiterates Solventum stock rating on revenue growth By Investing.com - Investing.com India
Solventum (NYSE:SOLV) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Solventum (NYSE:SOLV) Given Buy Rating at BTIG Research - MarketBeat
Demystifying Solventum: Insights From 5 Analyst Reviews - Benzinga
Jefferies Adjusts Price Target on Solventum to $84 From $75, Maintains Hold Rating - marketscreener.com
Solventum exceeds earnings estimates in first year as solo company - MassDevice
Solventum (NYSE:SOLV) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Solventum Q4 FY25 slides: organic growth solid despite earnings miss By Investing.com - Investing.com South Africa
Earnings call transcript: Solventum Q4 2025 misses EPS expectations - Investing.com
Solventum (NYSE:SOLV) Updates FY 2026 Earnings Guidance - MarketBeat
SOLVENTUM ($SOLV) Releases Q4 2025 Earnings - Quiver Quantitative
Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Solventum (SOLV) Surpasses Q4 Earnings and Revenue Estimates - Nasdaq
Solventum's (NYSE:SOLV) Q4 CY2025 Sales Top Estimates - Finviz
Solventum Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:SOLV) 2026-02-26 - Seeking Alpha
Solventum Q4 Earnings Rise, Revenue Declines; Guidance Set - marketscreener.com
Solventum Corporation Announces Increase In Q4 Income - Nasdaq
Solventum: Q4 Earnings Snapshot - marketscreener.com
Solventum (SOLV) Q4 2025 Earnings Call Transcript - The Globe and Mail
Solventum Q4 Earnings Summary & Key Takeaways - Benzinga
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance - PR Newswire
Solventum faces earnings test on growth targets after 3M spin-off - Investing.com
JPMorgan Chase & Co. Buys 61,507 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum: Fourth Quarter Financial Overview - Bitget
What To Expect From Solventum's (SOLV) Q4 Earnings - Finviz
Assessing Solventum (SOLV) Valuation After Recent Share Price Weakness And Operational Streamlining Progress - simplywall.st
Solventum Corporation (SOLV) Stock Analysis: Exploring a Potential 22% Upside in the Healthcare Sector - DirectorsTalk Interviews
Curious about Solventum (SOLV) Q4 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Solventum to Post Q4 Earnings: What's in Store for the Stock? - Yahoo Finance
Clark Estates Inc. NY Invests $11.32 Million in Solventum Corporation $SOLV - MarketBeat
Vanguard Group Inc. Has $1.25 Billion Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Stock Jumps After $4.1B Deal With Thermo Fisher - MSN
Pzena Investment Management LLC Takes $31.70 Million Position in Solventum Corporation $SOLV - MarketBeat
$3.8 Billion Negative Pressure Wound Therapy (NPWT) Devices Market Assessment, 2030Featuring Solventum, Smith+Nephew, Cardinal Health, Molnlycke Health Care, ConvaTec Group and Other Key Players - Yahoo Finance
PNC Financial Services Group Inc. Lowers Stock Position in Solventum Corporation $SOLV - MarketBeat
Solventum (SOLV) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Thermo Fisher confirms agreement to buy Solventum filtration unit (update) - MSN
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business - MSN
Rhumbline Advisers Sells 28,163 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Corporation $SOLV Shares Acquired by LSV Asset Management - MarketBeat
Balanced View on Solventum: Differentiated Healthcare IT AI Offsets Early-Stage Turnaround Risk, Supporting a Hold Rating - TipRanks
Bastion Asset Management Inc. Buys Shares of 30,010 Solventum Corporation $SOLV - MarketBeat
How Solventum Corporation stock trades during market volatilityGold Moves & Expert Curated Trade Setups - mfd.ru
Illinois Municipal Retirement Fund Purchases 18,209 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum (SOLV) Valuation Check After Recent Share Price Softness - Yahoo Finance
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Hold" from Analysts - MarketBeat
Solventum Expands MedSurg With Acera Deal As Valuation Signals Upside - Sahm
Is Solventum Corporation stock trending bullish2025 Technical Patterns & AI Powered Market Entry Strategies - mfd.ru
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):